High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3
Rui Guo, Ningning Liu, Hao Liu, Junhua Zhang, Han Zhang, Yingchao Wang, Yingchao Wang, Mirko Baruscotti, Lu Zhao, Yì Wáng, Yì Wáng
Topics & Concepts
Muscle hypertrophyPhenylephrineHeart failureInternal medicineEndocrinologyMedicinePharmacologyEjection fractionSIRT3Angiotensin IIChemistryReceptorAcetylationBiochemistrySirtuinBlood pressureGeneTraditional Chinese Medicine AnalysisMedicinal Plants and Bioactive CompoundsCardiac Fibrosis and Remodeling